From  16th to 18th April, our process specialists will be glad to present the latest developments: RheaLyo™ mono freeze-dryer: our Single Vial Unit for R&D. Fast formulation and process development. RheaLyo™ multi freeze-dryer: our machine for non-GMP stability batch productions. RheaLyo™ GMP-Flex™ production lines: for clinical and commercial productions.

On March 14 & 15 we attended the Advanced Therapies Congress in London where we presented a new poster on avoiding cold chain logistic challenges by using freeze-drying to stabilize gene therapies.

RheaVita will participate in the 7th Commercializing Continuous Processing in Pharma Summit in Boston.

The first exhibition of the year we will participate in is PharmaPack Europe, Paris Expo, Porte de Versailles – Hall 7.2. Taking place February 1&2 in Paris, France.

Our business development director, Jan Van Hauwermeiren, will represent RheaVita at CPHI taking place November 1-3 2022 in Frankfurt.

We attended the BIOPROCESS INTERNATIONAL and CELL & GENE THERAPY MANUFACTURING & COMMERCIALIZATION conference in Boston